What is it about?

Across two population-based cohorts, fat mass ratio – a DEXA-based biomarker of fat distribution previously proposed as a means of discriminating partial lipodystrophy – is associated with increased risk of cardiometabolic diseases, fasting insulin, and fasting triglycerides.

Featured Image

Read the Original

This page is a summary of: Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits, Diabetes, February 2024, American Diabetes Association,
DOI: 10.2337/db23-0575.
You can read the full text:

Read

Contributors

Be the first to contribute to this page